Chemical Component Summary

Name1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine
SynonymsCrenolanib
Identifiers1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
FormulaC26 H29 N5 O2
Molecular Weight443.54
TypeNON-POLYMER
Isomeric SMILESCC1(COC1)COc2ccc3c(c2)ncn3c4ccc5cccc(c5n4)N6CCC(CC6)N
InChIInChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3
InChIKeyDYNHJHQFHQTFTP-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count62
Chiral Atom Count0
Bond Count67
Aromatic Bond Count21

Drug Info: DrugBank

DrugBank IDDB11832 
NameCrenolanib
Groupsinvestigational
DescriptionCrenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.
SynonymsCrenolanib
Categories
  • Antineoplastic Agents
  • Heterocyclic Compounds, Fused-Ring
  • Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors
  • Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors
  • Tyrosine Kinase Inhibitors
CAS number670220-88-9

Related Resource References

Resource NameReference
PubChem10366136
ChEBICHEBI:145365
ChEMBLCHEMBL2105728
PharosCHEMBL2105728